Steroids inhalation therapy in chronic eosinophilic pneumonia

Steroids inhalation therapy in chronic eosinophilic pneumonia - Eosinophilic pneumonia

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000030830

Enrollment

Registered

2018-01-16

Start date

1999-12-31

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Eosinophilic pneumonia

Interventions

In December 1999, a 15-year-old girl was referred to Habikino hospital for evaluation of respiratory symptoms. BALF, Peripheral blood.process of treatments with ICS.

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Eosinophilic pneumonia, a case report.

Exclusion criteria

Exclusion criteria: Nothing

Design outcomes

Primary

Measure	Time frame
CD25 expression on CD4-positive T-lymphocytes was also increased (25.5 %) in the BALF compared to that on those in the peripheral blood (15.5 %).	—

Secondary

Measure	Time frame
We tried many ICSs on remmission and acute phase but obtained enough effect in eosinophilic pneumonia.	—

Countries

Japan

Contacts

Public ContactNorihide Murayama

Murayama Pediatrics Pediatrics

norihide99@yahoo.co.jp06-6790-8835

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026